Extracellular matrix remodeling factors

Extracellular matrix remodeling factors comprise a large and diverse group of enzymes and proteins responsible for the controlled degradation, synthesis, and modification of ECM components such as collagens, laminins, proteoglycans, and glycoproteins[1][2][3]. These factors are central to normal biological processes including development, tissue repair, wound healing, and immune cell migration. Key classes include matrix metalloproteinases (MMPs), serine and cysteine proteases, lysyl oxidases, and related enzymes. Dysregulation of ECM remodeling leads to pathological conditions such as cancer metastasis, organ fibrosis, chronic inflammation, and tissue degeneration[1][2][6]. Individual members within this group are established therapeutic targets and biomarkers; however, "extracellular matrix remodeling factors" as a category is too broad to represent a single therapeutic target.

Other names

ECM remodeling enzymesMatrix remodeling factorsECM modifying enzymesExtracellular proteases

Enzyme inhibition (protease, oxidase, glycosidase inhibition to prevent ECM degradation or crosslinking)\nRegulation of gene expression (transcriptional suppression of remodeling factor genes)\nModulation of enzyme activation or activity (e.g., pro-enzyme activation inhibition)\nNeutralization of downstream signaling (e.g., blocking growth factors released upon ECM degradation)[4]